Actively Recruiting
General Anesthesia vs Conscious Sedation for Radial Endobronchial Ultrasound
Led by Institut universitaire de cardiologie et de pneumologie de Québec, University Laval · Updated on 2026-03-06
306
Participants Needed
1
Research Sites
200 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The endoscopic investigation of lung lesions is experiencing significant growth with the increasing number of lung cancer screening programs. Peripheral endobronchial ultrasound (pEBUS) is the most widely used endoscopic technique in the investigation of peripheral pulmonary lesions (PPL). It is performed in relatively equal proportions under conscious sedation and general anesthesia by interventional pulmonologists throughout the world. Users of conscious sedation justify themselves by the fewer resources consumed and the absence of demonstration of a superior diagnostic yield of general anesthesia while users of general anesthesia claim diagnostic yield and comfort for the patient are superior with their approach. Our main objective is to compare the diagnostic yield of pEBUS under general anesthesia to that obtained under conscious sedation.
CONDITIONS
Official Title
General Anesthesia vs Conscious Sedation for Radial Endobronchial Ultrasound
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older with ability to consent
- Peripheral lung lesion less than 5 cm in diameter on CT scan
- Lesion accessible to pEBUS as determined by an experienced interventional pulmonologist
- Agreement by medical team and patient to use pEBUS for diagnosis of lung lesion
You will not qualify if you...
- Use of electromagnetic navigation, augmented fluoroscopy, or robotic bronchoscopy planned in addition to pEBUS
- Suspicious lymph nodes 10 mm or larger or with moderate or greater hypermetabolism accessible by linear EBUS
- Contraindications to bronchoscopy or biopsy such as unstable medical condition or uncorrected bleeding risk
- Current pregnancy
- Lack of free and informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Institut universitaire de cardiologie et de pneumologie de Québec
Québec, Quebec, Canada, G1V 4G5
Actively Recruiting
Research Team
M
Marc Fortin, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here